Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Notes on a Case of Congenital Absence of Both Eyeballs.

The Indian medical gazette

Carr-White P.
PMID: 29002969
Ind Med Gaz. 1903 Feb;38(2):58-59.

No abstract available.

Cite
Carr-White P. Notes on a Case of Congenital Absence of Both Eyeballs. Ind Med Gaz. 1903;38(2):58-59
Carr-White, P. (1903). Notes on a Case of Congenital Absence of Both Eyeballs. The Indian medical gazette, 38(2), 58-59.
Carr-White, P. "Notes on a Case of Congenital Absence of Both Eyeballs." The Indian medical gazette vol. 38,2 (1903): 58-59.
Carr-White P. Notes on a Case of Congenital Absence of Both Eyeballs. Ind Med Gaz. 1903 Feb;38(2):58-59. PMID: 29002969; PMCID: PMC5150726.
Copy Download .nbib Format: NLM
A case of mistaken arrhythmogenic identity during pregnancy.

Clinical case reports

Asher C, Thomas T, Rinaldi CA, Carr-White G.
PMID: 34386235
Clin Case Rep. 2021 Aug 06;9(8):e04561. doi: 10.1002/ccr3.4561. eCollection 2021 Aug.

Atypical LVOT ectopy can present with an RVOT morphology on ECG and differentiation to reveal this focus is in favor of benign idiopathic ventricular ectopy over an arrhythmogenic cardiomyopathy.

Cite
Asher C, Thomas T, Rinaldi CA, et al. A case of mistaken arrhythmogenic identity during pregnancy. Clin Case Rep. 2021;9(8):e04561doi: 10.1002/ccr3.4561.
Asher, C., Thomas, T., Rinaldi, C. A., & Carr-White, G. (2021). A case of mistaken arrhythmogenic identity during pregnancy. Clinical case reports, 9(8), e04561. https://doi.org/10.1002/ccr3.4561
Asher, Clint, et al. "A case of mistaken arrhythmogenic identity during pregnancy." Clinical case reports vol. 9,8 (2021): e04561. doi: https://doi.org/10.1002/ccr3.4561
Asher C, Thomas T, Rinaldi CA, Carr-White G. A case of mistaken arrhythmogenic identity during pregnancy. Clin Case Rep. 2021 Aug 06;9(8):e04561. doi: 10.1002/ccr3.4561. eCollection 2021 Aug. PMID: 34386235; PMCID: PMC8344966.
Copy Download .nbib Format: NLM
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.

Heart (British Cardiac Society)

Brownrigg JR, Leo V, Rose J, Low E, Richards S, Carr-White G, Elliott PM.
PMID: 34969871
Heart. 2021 Dec 30; doi: 10.1136/heartjnl-2021-320181. Epub 2021 Dec 30.

AIMS: The population prevalence of cardiomyopathies and the natural history of symptomatic heart failure (HF) and arrhythmia across cardiomyopathy phenotypes is poorly understood. Study aims were to estimate the population-diagnosed prevalence of cardiomyopathies and describe the temporal relationship between...

Cite
Brownrigg JR, Leo V, Rose J, et al. Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study. Heart. 2021;doi: 10.1136/heartjnl-2021-320181.
Brownrigg, J. R., Leo, V., Rose, J., Low, E., Richards, S., Carr-White, G., & Elliott, P. M. (2021). Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study. Heart (British Cardiac Society), . https://doi.org/10.1136/heartjnl-2021-320181
Brownrigg, Jack Rw, et al. "Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study." Heart (British Cardiac Society) vol. (2021). doi: https://doi.org/10.1136/heartjnl-2021-320181
Brownrigg JR, Leo V, Rose J, Low E, Richards S, Carr-White G, Elliott PM. Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study. Heart. 2021 Dec 30; doi: 10.1136/heartjnl-2021-320181. Epub 2021 Dec 30. PMID: 34969871.
Copy Download .nbib Format: NLM
Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes.

International journal of cardiology. Heart & vasculature

Sidhu BS, Gould J, Elliott MK, Mehta VS, Niederer SA, Carr-White G, Rinaldi CA.
PMID: 34159251
Int J Cardiol Heart Vasc. 2021 Jun 09;34:100800. doi: 10.1016/j.ijcha.2021.100800. eCollection 2021 Jun.

BACKGROUND: Pre-procedural assessment of patients undergoing cardiac resynchronization therapy (CRT) is heterogenous and patients implanted with unfavorable characteristics may account for non-response. A dedicated CRT pre-assessment clinic (CRT PAC) was developed to standardize the review process and undertake structured...

Cite
Sidhu BS, Gould J, Elliott MK, et al. Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes. Int J Cardiol Heart Vasc. 2021;34:100800doi: 10.1016/j.ijcha.2021.100800.
Sidhu, B. S., Gould, J., Elliott, M. K., Mehta, V. S., Niederer, S. A., Carr-White, G., & Rinaldi, C. A. (2021). Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes. International journal of cardiology. Heart & vasculature, 34100800. https://doi.org/10.1016/j.ijcha.2021.100800
Sidhu, Baldeep S, et al. "Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes." International journal of cardiology. Heart & vasculature vol. 34 (2021): 100800. doi: https://doi.org/10.1016/j.ijcha.2021.100800
Sidhu BS, Gould J, Elliott MK, Mehta VS, Niederer SA, Carr-White G, Rinaldi CA. Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes. Int J Cardiol Heart Vasc. 2021 Jun 09;34:100800. doi: 10.1016/j.ijcha.2021.100800. eCollection 2021 Jun. PMID: 34159251; PMCID: PMC8203725.
Copy Download .nbib Format: NLM
The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy.

International journal of cardiology. Heart & vasculature

Jackson T, Amraoui S, Sohal M, Sammut E, Behar JM, Claridge S, Webb J, Sienecwicz B, Razavi R, Rinaldi CA, Carr-White G.
PMID: 29750182
Int J Cardiol Heart Vasc. 2017 Dec 13;18:81-85. doi: 10.1016/j.ijcha.2017.11.005. eCollection 2018 Mar.

BACKGROUND: Trials using echocardiographic mechanical dyssynchrony (MD) parameters in narrow QRS patients have shown a negative response to CRT. We hypothesized MD in these patients may relate to myocardial scar rather than electrical dyssynchrony.METHODS: We determined the prevalence of...

Cite
Jackson T, Amraoui S, Sohal M, et al. The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy. Int J Cardiol Heart Vasc. 2017;18:81-85doi: 10.1016/j.ijcha.2017.11.005.
Jackson, T., Amraoui, S., Sohal, M., Sammut, E., Behar, J. M., Claridge, S., Webb, J., Sienecwicz, B., Razavi, R., Rinaldi, C. A., & Carr-White, G. (2018). The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy. International journal of cardiology. Heart & vasculature, 1881-85. https://doi.org/10.1016/j.ijcha.2017.11.005
Jackson, Tom, et al. "The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy." International journal of cardiology. Heart & vasculature vol. 18 (2018): 81-85. doi: https://doi.org/10.1016/j.ijcha.2017.11.005
Jackson T, Amraoui S, Sohal M, Sammut E, Behar JM, Claridge S, Webb J, Sienecwicz B, Razavi R, Rinaldi CA, Carr-White G. The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy. Int J Cardiol Heart Vasc. 2017 Dec 13;18:81-85. doi: 10.1016/j.ijcha.2017.11.005. eCollection 2018 Mar. PMID: 29750182; PMCID: PMC5941225.
Copy Download .nbib Format: NLM
Is Antivenine of Any Value in Cobra Poisoning?.

The Indian medical gazette

Carr-White P.
PMID: 29003571
Ind Med Gaz. 1902 Nov;37(11):431-434.

No abstract available.

Cite
Carr-White P. Is Antivenine of Any Value in Cobra Poisoning?. Ind Med Gaz. 1902;37(11):431-434
Carr-White, P. (1902). Is Antivenine of Any Value in Cobra Poisoning?. The Indian medical gazette, 37(11), 431-434.
Carr-White, P. "Is Antivenine of Any Value in Cobra Poisoning?." The Indian medical gazette vol. 37,11 (1902): 431-434.
Carr-White P. Is Antivenine of Any Value in Cobra Poisoning?. Ind Med Gaz. 1902 Nov;37(11):431-434. PMID: 29003571; PMCID: PMC5156048.
Copy Download .nbib Format: NLM
Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study.

ESC heart failure

Cowie MR, Flett A, Cowburn P, Foley P, Chandrasekaran B, Loke I, Critoph C, Gardner RS, Guha K, Betts TR, Carr-White G, Zaidi A, Lim HS, Hayward C, Patwala A, Rogers D, Pettit S, Gazzola C, Henderson J, Adamson PB.
PMID: 34882989
ESC Heart Fail. 2021 Dec 09; doi: 10.1002/ehf2.13748. Epub 2021 Dec 09.

AIMS: The CardioMEMS HF System Post-Market Study (COAST) was designed to evaluate the safety, effectiveness, and feasibility of haemodynamic-guided heart failure (HF) management using a small sensor implanted in the pulmonary artery of New York Heart Association (NYHA) Class...

Cite
Cowie MR, Flett A, Cowburn P, et al. Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study. ESC Heart Fail. 2021;doi: 10.1002/ehf2.13748.
Cowie, M. R., Flett, A., Cowburn, P., Foley, P., Chandrasekaran, B., Loke, I., Critoph, C., Gardner, R. S., Guha, K., Betts, T. R., Carr-White, G., Zaidi, A., Lim, H. S., Hayward, C., Patwala, A., Rogers, D., Pettit, S., Gazzola, C., Henderson, J., & Adamson, P. B. (2021). Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study. ESC heart failure, . https://doi.org/10.1002/ehf2.13748
Cowie, Martin R, et al. "Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study." ESC heart failure vol. (2021). doi: https://doi.org/10.1002/ehf2.13748
Cowie MR, Flett A, Cowburn P, Foley P, Chandrasekaran B, Loke I, Critoph C, Gardner RS, Guha K, Betts TR, Carr-White G, Zaidi A, Lim HS, Hayward C, Patwala A, Rogers D, Pettit S, Gazzola C, Henderson J, Adamson PB. Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study. ESC Heart Fail. 2021 Dec 09; doi: 10.1002/ehf2.13748. Epub 2021 Dec 09. PMID: 34882989.
Copy Download .nbib Format: NLM
Limited availability of cardiac rehabilitation for heart failure patients in the United Kingdom: findings from a national survey.

European journal of preventive cardiology

Buttery AK, Carr-White G, Martin FC, Glaser K, Lowton K.
PMID: 23513012
Eur J Prev Cardiol. 2014 Aug;21(8):928-40. doi: 10.1177/2047487313482286. Epub 2013 Mar 19.

BACKGROUND: Participation of patients with heart failure in cardiac rehabilitation in the UK is low. This study investigated the availability of cardiac rehabilitation services for patients with heart failure in the UK and the views of service coordinators on...

Cite
Buttery AK, Carr-White G, Martin FC, et al. Limited availability of cardiac rehabilitation for heart failure patients in the United Kingdom: findings from a national survey. Eur J Prev Cardiol. 2013;21(8):928-40doi: 10.1177/2047487313482286.
Buttery, A. K., Carr-White, G., Martin, F. C., Glaser, K., & Lowton, K. (2014). Limited availability of cardiac rehabilitation for heart failure patients in the United Kingdom: findings from a national survey. European journal of preventive cardiology, 21(8), 928-40. https://doi.org/10.1177/2047487313482286
Buttery, Amanda K, et al. "Limited availability of cardiac rehabilitation for heart failure patients in the United Kingdom: findings from a national survey." European journal of preventive cardiology vol. 21,8 (2014): 928-40. doi: https://doi.org/10.1177/2047487313482286
Buttery AK, Carr-White G, Martin FC, Glaser K, Lowton K. Limited availability of cardiac rehabilitation for heart failure patients in the United Kingdom: findings from a national survey. Eur J Prev Cardiol. 2014 Aug;21(8):928-40. doi: 10.1177/2047487313482286. Epub 2013 Mar 19. PMID: 23513012.
Copy Download .nbib Format: NLM
Atrial Tachycardia in a Patient With Fabry's Disease.

HeartRhythm case reports

Marek Kiedrowicz R, Cooklin M, Carr-White G, O'Neill M.
PMID: 28491649
HeartRhythm Case Rep. 2015 Dec 19;2(2):124-127. doi: 10.1016/j.hrcr.2015.10.007. eCollection 2016 Mar.

No abstract available.

Cite
Marek Kiedrowicz R, Cooklin M, Carr-White G, et al. Atrial Tachycardia in a Patient With Fabry's Disease. HeartRhythm Case Rep. 2015;2(2):124-127doi: 10.1016/j.hrcr.2015.10.007.
Marek Kiedrowicz, R., Cooklin, M., Carr-White, G., & O'Neill, M. (2016). Atrial Tachycardia in a Patient With Fabry's Disease. HeartRhythm case reports, 2(2), 124-127. https://doi.org/10.1016/j.hrcr.2015.10.007
Marek Kiedrowicz, Radoslaw, et al. "Atrial Tachycardia in a Patient With Fabry's Disease." HeartRhythm case reports vol. 2,2 (2016): 124-127. doi: https://doi.org/10.1016/j.hrcr.2015.10.007
Marek Kiedrowicz R, Cooklin M, Carr-White G, O'Neill M. Atrial Tachycardia in a Patient With Fabry's Disease. HeartRhythm Case Rep. 2015 Dec 19;2(2):124-127. doi: 10.1016/j.hrcr.2015.10.007. eCollection 2016 Mar. PMID: 28491649; PMCID: PMC5412633.
Copy Download .nbib Format: NLM
Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?.

International journal of cardiology. Heart & vasculature

Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G.
PMID: 30202782
Int J Cardiol Heart Vasc. 2018 Sep 06;21:1-6. doi: 10.1016/j.ijcha.2018.06.001. eCollection 2018 Dec.

BACKGROUND: The new category of heart failure (HF), Heart Failure with mid range Ejection Fraction (HFmrEF) has recently been proposed with recent publications reporting that HFmrEF represents a transitional phase. The aim of this study was to determine the...

Cite
Webb J, Draper J, Fovargue L, et al. Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?. Int J Cardiol Heart Vasc. 2018;21:1-6doi: 10.1016/j.ijcha.2018.06.001.
Webb, J., Draper, J., Fovargue, L., Sieniewicz, B., Gould, J., Claridge, S., Barton, C., Smith, S., Tondel, K., Rajani, R., Kapetanakis, S., Rinaldi, C. A., McDonagh, T. A., Razavi, R., & Carr-White, G. (2018). Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?. International journal of cardiology. Heart & vasculature, 211-6. https://doi.org/10.1016/j.ijcha.2018.06.001
Webb, Jessica, et al. "Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?." International journal of cardiology. Heart & vasculature vol. 21 (2018): 1-6. doi: https://doi.org/10.1016/j.ijcha.2018.06.001
Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G. Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?. Int J Cardiol Heart Vasc. 2018 Sep 06;21:1-6. doi: 10.1016/j.ijcha.2018.06.001. eCollection 2018 Dec. PMID: 30202782; PMCID: PMC6128173.
Copy Download .nbib Format: NLM
Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy.

Health science reports

Asher C, Guilder A, Finocchiaro G, Carr-White G, Rodríguez-Guadarrama Y.
PMID: 35024457
Health Sci Rep. 2022 Jan 06;5(1):e466. doi: 10.1002/hsr2.466. eCollection 2022 Mar.

OBJECTIVES: Our primary aim was to evaluate the healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Second, we aim to assess the effect of the number of diagnostic tests and clinical contact points on the total...

Cite
Asher C, Guilder A, Finocchiaro G, et al. Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Health Sci Rep. 2022;5(1):e466doi: 10.1002/hsr2.466.
Asher, C., Guilder, A., Finocchiaro, G., Carr-White, G., & Rodríguez-Guadarrama, Y. (2022). Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Health science reports, 5(1), e466. https://doi.org/10.1002/hsr2.466
Asher, Clint, et al. "Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy." Health science reports vol. 5,1 (2022): e466. doi: https://doi.org/10.1002/hsr2.466
Asher C, Guilder A, Finocchiaro G, Carr-White G, Rodríguez-Guadarrama Y. Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Health Sci Rep. 2022 Jan 06;5(1):e466. doi: 10.1002/hsr2.466. eCollection 2022 Mar. PMID: 35024457; PMCID: PMC8733838.
Copy Download .nbib Format: NLM
Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK.

Heart (British Cardiac Society)

Sheikh N, Papadakis M, Panoulas VF, Prakash K, Millar L, Adami P, Zaidi A, Gati S, Wilson M, Carr-White G, Tomé MTE, Behr ER, Sharma S.
PMID: 27679836
Heart. 2016 Nov 15;102(22):1797-1804. doi: 10.1136/heartjnl-2016-309843. Epub 2016 Sep 27.

BACKGROUND: This study investigated the influence of African/Afro-Caribbean (black) ethnicity on the clinical profile and outcomes in hypertrophic cardiomyopathy (HCM).METHODS: 425 consecutive patients with HCM (163 black and 262 Caucasians (white); mean age 52.5±16.6 years) were assessed at three...

Cite
Sheikh N, Papadakis M, Panoulas VF, et al. Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK. Heart. 2016;102(22):1797-1804doi: 10.1136/heartjnl-2016-309843.
Sheikh, N., Papadakis, M., Panoulas, V. F., Prakash, K., Millar, L., Adami, P., Zaidi, A., Gati, S., Wilson, M., Carr-White, G., Tomé, M. T. E., Behr, E. R., & Sharma, S. (2016). Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK. Heart (British Cardiac Society), 102(22), 1797-1804. https://doi.org/10.1136/heartjnl-2016-309843
Sheikh, Nabeel, et al. "Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK." Heart (British Cardiac Society) vol. 102,22 (2016): 1797-1804. doi: https://doi.org/10.1136/heartjnl-2016-309843
Sheikh N, Papadakis M, Panoulas VF, Prakash K, Millar L, Adami P, Zaidi A, Gati S, Wilson M, Carr-White G, Tomé MTE, Behr ER, Sharma S. Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK. Heart. 2016 Nov 15;102(22):1797-1804. doi: 10.1136/heartjnl-2016-309843. Epub 2016 Sep 27. PMID: 27679836.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries